The price of global health: drug pricing strategies to balance patient access and the funding of innovation

Table of contents:

Chapter I The drug pricing challenge
Chapter II Payers
Chapter III Fundamentals of pricing
Chapter IV Reference-based pricing
Chapter V Health outcomes and health economics
Chapter VI Features, benefits, value, and price
Chapter VII Pricing and drug development
Chapter VIII Payer segmentation
Chapter IX Key situation factors: the podium approach
Chapter X The best price framework to pricing and market access
Chapter XI Payer value story
Chapter XII Developing a global pricing strategy
Chapter XII Public policy and ethical considerations
Chapter XIV Oncology and orphan drugs
Chapter XV Payer and pricing research
Chapter XVI Corporate market access and pricing function
Chapter XVII Market access and pricing negotiations
Chapter XVIII Risk sharing and managed entry agreements
Chapter XIX United states
Chapter XX Canada
Chapter XXI France
Chapter XXII Germany
Chapter XXIII Italy
Chapter XXIV Spain
Chapter XXV UK
Chapter XXVI Japan
Chapter XXVII Australia
Chapter XXVIII Brazil
Chapter XXIX China
Chapter XXX India
Chapter XXXI South Korea

Ed Schoonveld explains how pharmaceutical prices are determined in a complex global player environment and what factors influence the process. The Price of Global Health is the first book of its kind: an in-depth but straightforward exploration of the pharmaceutical pricing strategy process, its underlying market access.

https://www.routledge.com/The-Price-of-Global-Health-Drug-Pricing-Strategies-to-Balance-Patient/Schoonveld/p/book/9781472438805